METTL3 and hepatoblastoma: The miR-186/METTL3 axis promoted the proliferation and migration of Hepatoblastoma cells through the Wnt/β-catenin signaling pathway, which might be a target for the treatment of Hepatoblastoma (Cui et al., 2020).